Markets
HAE

Haemonetics Turns To Profit In Q1 - Quick Facts

(RTTNews) - Healthcare company Haemonetics Corp. (HAE) reported Tuesday a net income for the first quarter of $10.53 million or $0.21 per share, compared to a net loss of $8.48 million or $0.17 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.46 per share, compared to last year's $0.81 per share.

Net revenue for the quarter decreased 18.0 percent to $195.58 million from last year's $238.45 million. Organic revenue was down 15.6 percent.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.41 per share on revenue of $198.27 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead, the company said it did not issue fiscal 2021 guidance due to the continued uncertainty about the pace and timing of the COVID-19 pandemic and recovery. As a result, the Company intends to issue guidance later in its fiscal year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

HAE

Latest Markets Videos

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More